SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-056160
Filing Date
2010-11-05
Accepted
2010-11-04 17:37:51
Documents
11
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-17436_110q.htm 10-Q 1123398
2 EX-10.1 a10-17436_1ex10d1.htm EX-10.1 40678
3 EX-31.1 a10-17436_1ex31d1.htm EX-31.1 9711
4 EX-31.2 a10-17436_1ex31d2.htm EX-31.2 9752
5 EX-32.1 a10-17436_1ex32d1.htm EX-32.1 7497
  Complete submission text file 0001104659-10-056160.txt   4259888

Data Files

Seq Description Document Type Size
6 EX-101.INS isis-20100930.xml EX-101.INS 641658
7 EX-101.SCH isis-20100930.xsd EX-101.SCH 17008
8 EX-101.CAL isis-20100930_cal.xml EX-101.CAL 39323
9 EX-101.DEF isis-20100930_def.xml EX-101.DEF 65782
10 EX-101.LAB isis-20100930_lab.xml EX-101.LAB 193059
11 EX-101.PRE isis-20100930_pre.xml EX-101.PRE 96335
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 101166042
SIC: 2834 Pharmaceutical Preparations